Rising medication costs are no longer cyclical — they are structural.
Across ASEAN, healthcare inflation continues to outpace general inflation, with pharmaceutical spending emerging as one of the most volatile components. While many organisations focus on negotiating better drug prices, evidence consistently shows that prescribing behaviour, utilisation oversight and governance discipline are equally critical in determining long-term sustainability.
This programme provides a structured and practical understanding of Pharmacy Benefit Management (PBM) — not merely as a pricing tool, but as a system for influencing prescribing patterns, managing utilisation and ensuring sustainable healthcare financing.
This session is designed to move beyond theory and into practical execution.
